Presentations
Oncoinvent regularly presents clinical and pre-clinical data at leading scientific congresses and shares company updates at investor relation conferences. Below are presentations given by the company’s senior management and clinical collaborators.
2025
Webcast Merger with Oncoinvent ASA, English 10am CEST
Webcast in Norwegian, presentation of Oncoinvent ASA 11am CEST
2024
DNB Nordic Healthcare Conference November 2024
Wainright Conference September 2024
Carnegie Nordic Healthcare, March 2024
2023
DNB Conference Presentation, December 2023
H.C. Wainwright 25th Annual Global Investment Conference, September 2023
Arctic Securities and Carnegie webcast 2 June 2023
BerGenBio business update May 2023
Carnegie Health Care Seminar March 2023
2022
Nordic Healthcare Conference 2022, 15 December 2022
Pareto Securities’ 13th Annual Healthcare Conference
ABGSE Life Science Summit
Strategy update, audio cast
Arctic Securities Biotech Webinar
Carnegie virtual Nordic Healthcare seminar
2021
DNB Nordic Healthcare Conference 2021, 16 December 2021
SACHS 7th Annual Immuno-Oncology Innovation Forum 2021
BerGenBio Webcast 18 May 2021
Arctic Securities Biotech Webinar 2021
BerGenBio Corporate Update April 2021
Carnegie Virtual Healthcare Seminar 2021
SACHS Annual European Life Sciences CEO Forum
H.C. Wainwright Global Life Sciences Conference 2021
SEB Annual Healthcare Seminar 2021
BerGenBio Corporate Update 2021
2020
DNB Nordic Healthcare Conference 2020
5th Annual Nordic-American Life Science Conference
Solebury Trout Podcast Interview, 30th November 2020
Sachs Annual Biotech in Europe Forum
H. C. Wainwright 22nd Annual Global Investment Conference
Solebury Trout Zoomside Chat, 1st September
Pareto Securities 11th Healthcare Conference, 3 September 2020
LSX Nordic Congress, 1-4 September 2020
SACHS Digital Novel Coronavirus Investment Forum 9 July 2020
Virtual European Biotech Investor day Solebury Trout 25 June 2020
ABG Sundal Collier Virtual Oncology Seminar 10 june 2020
BerGenBio Corporate update May 2020
COVID-19 webcast 29 April 2020
Solebury Trout Virtual Global Healthcare Conference
SEB Annual Pharma & Biotech Seminar
BerGenBio corporate update
2019
H.C. Wainwright 21st Annual Global Life Sciences Conference
BerGenBio Corporate Update
BerGenBio ASCO 2018 investor call: June 4 2018 at 15:30 CET
H.C. Wainwright Global Life Sciences Conference
BerGenBio Corporate Update
Webcast Nordnet
Biotech Showcase
2018
DNB 9th Annual Nordic Healthcare Conference
DnB Nordic American Life-Science Conference 2018
H.C. Wainwright 20th Annual Global Investment Conference 2018
Norne Securities – Vestlandsbørsen
BerGenBio ASCO 2018 investor call: June 4 2018 at 8:30 AM CEST.
Bio€quity Europe
BerGenBio Corporate Update
Biotech Showcase 2018
2017
8th Annual Nordic Healthcare Conference
Carnegie Nordic Healthcare Day
Jefferies Global Healthcare Conference
2025
H1 Financial report
2024
Annual Report 2024
Q4 2024 Report
Q3 2024 Report
Q2 2024 Report
Q1 2024 Report
Supplemental prospectus 19 February 2024
2023
Annual Report 2023
Q4 2023 Report
Prospectus 7 December 2023
Q3 2023 Report
Q2 2023 Report
Q1 2023 Report
Prospectus Rights issue 2023
2022
Annual Report 2022
Q4 2022 Report
Q3 2022 Report
Q2 2022 Report
Q1 2022 Report
2021
Annual Report 2021
Q4 and FY 2021 Report
Q3 2021 Report
Q2 2021 Report
Q1 2021 Report
2020
Annual Report 2020
Q4 and FY 2020 Report
Q3 2020 Report
Q2 2020 Report
Prospectus 19 June 2020 BGBIO
Q1 2020 Report
Prospectus 26 February 2020 BGBIO
2019
Annual Report 2019
Q4 and FY 2019 Report
Q3 2019 Report
Q2 2019 Report
Q1 2019 Report
2018
Annual Report 2018
Q4 and FY 2018 Report
Q3 2018 Report
Q2 2018 Report
Q1 2018 Report
Prospectus regarding listing of shares under the Share Option Programme
2017
Q4 and FY 2017 Report
Q3 2017 Report
Q2 2017 Report
Q1 2017 Report
Annual Report 2017
IPO prospectus
2016
Annual Report 2016
2015
Annual Report 2015
2014
Annual Report 2014